Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 176

1.

A let-7 microRNA-Binding Site Polymorphism in KRAS Predicts Improved Outcome in Patients with Metastatic Colorectal Cancer Treated with Salvage Cetuximab/Panitumumab Monotherapy.

Saridaki Z, Weidhaas JB, Lenz HJ, Laurent-Puig P, Jacobs B, De Schutter J, De Roock W, Salzman DW, Zhang W, Yang D, Pilati C, Bouché O, Piessevaux H, Tejpar S.

Clin Cancer Res. 2014 Sep 1;20(17):4499-510. doi: 10.1158/1078-0432.CCR-14-0348.

PMID:
25183481
[PubMed - in process]
2.

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial.

Adenis A, Blay JY, Bui-Nguyen B, Bouché O, Bertucci F, Isambert N, Bompas E, Chaigneau L, Domont J, Ray-Coquard I, Blésius A, Van Tine BA, Bulusu VR, Dubreuil P, Mansfield CD, Acin Y, Moussy A, Hermine O, Le Cesne A.

Ann Oncol. 2014 Sep;25(9):1762-9. doi: 10.1093/annonc/mdu237. Epub 2014 Jul 25.

PMID:
25122671
[PubMed - in process]
Free PMC Article
3.

Conservative surgery vs. duodeneopancreatectomy in primary duodenal gastrointestinal stromal tumors (GIST): A retrospective review of 114 patients from the French Sarcoma Group (FSG).

Duffaud F, Meeus P, Bachet JB, Cassier P, Huynh TK, Boucher E, Bouché O, Moutardier V, le Cesne A, Landi B, Marchal F, Bay JO, Bertucci F, Spano JP, Stoeckle E, Collard O, Chaigneau L, Isambert N, Lebrun-Ly V, Mancini J, Blay JY, Bonvalot S.

Eur J Surg Oncol. 2014 May 28. pii: S0748-7983(14)00430-2. doi: 10.1016/j.ejso.2014.04.011. [Epub ahead of print]

PMID:
24994075
[PubMed - as supplied by publisher]
4.

[External review of integrative oncology or complementary therapies use. Based on US academic cancer center].

Brami C, Bouché O, Karp JC, Curé H.

Bull Cancer. 2014 Jun;101(6):531-2. doi: 10.1684/bdc.2014.1980. French. No abstract available.

PMID:
24977442
[PubMed - indexed for MEDLINE]
5.

Primary tumor resection in colorectal cancer with unresectable synchronous metastases: A review.

de Mestier L, Manceau G, Neuzillet C, Bachet JB, Spano JP, Kianmanesh R, Vaillant JC, Bouché O, Hannoun L, Karoui M.

World J Gastrointest Oncol. 2014 Jun 15;6(6):156-69. doi: 10.4251/wjgo.v6.i6.156. Review.

PMID:
24936226
[PubMed]
Free PMC Article
6.

Infrared spectral histopathology for cancer diagnosis: a novel approach for automated pattern recognition of colon adenocarcinoma.

Nallala J, Diebold MD, Gobinet C, Bouché O, Sockalingum GD, Piot O, Manfait M.

Analyst. 2014 Aug 21;139(16):4005-15. doi: 10.1039/c3an01022h.

PMID:
24932462
[PubMed - in process]
7.

Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy.

Manceau G, Imbeaud S, Thiébaut R, Liébaert F, Fontaine K, Rousseau F, Génin B, Le Corre D, Didelot A, Vincent M, Bachet JB, Chibaudel B, Bouché O, Landi B, Bibeau F, Leroy K, Penault-Llorca F, Van Laethem JL, Demetter P, Tejpar S, Rossi S, Mosakhani N, Osterlund P, Ristamäki R, Sarhadi V, Knuutila S, Boige V, André T, Laurent-Puig P.

Clin Cancer Res. 2014 Jun 15;20(12):3338-47. doi: 10.1158/1078-0432.CCR-13-2750. Epub 2014 Apr 25.

PMID:
24771647
[PubMed - in process]
8.

Primary rectal cancer local staging.

Hoeffel C, Mulé S, Laurent V, Bouché O, Volet J, Soyer P.

Diagn Interv Imaging. 2014 May;95(5):485-94. doi: 10.1016/j.diii.2014.03.005. Epub 2014 Apr 2.

PMID:
24703376
[PubMed - in process]
9.

Is primary tumor resection associated with a longer survival in colon cancer and unresectable synchronous metastases? A 4-year multicentre experience.

de Mestier L, Neuzillet C, Pozet A, Desot E, Deguelte-Lardière S, Volet J, Karoui M, Kianmanesh R, Bonnetain F, Bouché O.

Eur J Surg Oncol. 2014 Jun;40(6):685-91. doi: 10.1016/j.ejso.2014.02.236. Epub 2014 Feb 28.

PMID:
24630774
[PubMed - indexed for MEDLINE]
10.

Primary localized rectal/pararectal gastrointestinal stromal tumors: results of surgical and multimodal therapy from the French Sarcoma group.

Huynh TK, Meeus P, Cassier P, Bouché O, Lardière-Deguelte S, Adenis A, André T, Mancini J, Collard O, Montemurro M, Bompas E, Rios M, Isambert N, Cupissol D, Blay JY, Duffaud F.

BMC Cancer. 2014 Mar 5;14:156. doi: 10.1186/1471-2407-14-156.

PMID:
24597959
[PubMed - in process]
Free PMC Article
11.

Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial.

Conroy T, Galais MP, Raoul JL, Bouché O, Gourgou-Bourgade S, Douillard JY, Etienne PL, Boige V, Martel-Lafay I, Michel P, Llacer-Moscardo C, François E, Créhange G, Abdelghani MB, Juzyna B, Bedenne L, Adenis A; Fédération Francophone de Cancérologie Digestive and UNICANCER-GI Group.

Lancet Oncol. 2014 Mar;15(3):305-14. doi: 10.1016/S1470-2045(14)70028-2. Epub 2014 Feb 18.

PMID:
24556041
[PubMed - indexed for MEDLINE]
12.

Prognostic value of skin manifestations of infective endocarditis.

Servy A, Valeyrie-Allanore L, Alla F, Lechiche C, Nazeyrollas P, Chidiac C, Hoen B, Chosidow O, Duval X; Association Pour l'Etude et la Prévention de l'Endocardite Infectieuse Study Group.

JAMA Dermatol. 2014 May;150(5):494-500.

PMID:
24500311
[PubMed - indexed for MEDLINE]
13.

Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial.

Samalin E, Bouché O, Thézenas S, Francois E, Adenis A, Bennouna J, Taieb J, Desseigne F, Seitz JF, Conroy T, Galais MP, Assenat E, Crapez E, Poujol S, Bibeau F, Boissière F, Laurent-Puig P, Ychou M, Mazard T.

Br J Cancer. 2014 Mar 4;110(5):1148-54. doi: 10.1038/bjc.2013.813. Epub 2014 Jan 9.

PMID:
24407191
[PubMed - indexed for MEDLINE]
14.

Infrared and Raman imaging for characterizing complex biological materials: a comparative morpho-spectroscopic study of colon tissue.

Nallala J, Piot O, Diebold MD, Gobinet C, Bouché O, Manfait M, Sockalingum GD.

Appl Spectrosc. 2014 Jan;68(1):57-68. doi: 10.1366/13-07170.

PMID:
24405955
[PubMed - in process]
15.

Filiform polyposis: A benign entity? Case report and literature review.

Boulagnon C, Jazeron JF, Diaz-Cives A, Ehrhard F, Bouché O, Diebold MD.

Pathol Res Pract. 2014 Mar;210(3):189-93. doi: 10.1016/j.prp.2013.11.001. Epub 2013 Nov 15.

PMID:
24315830
[PubMed - in process]
16.

Value of diffusion-weighted and gadolinium-enhanced MRI for the diagnosis of pelvic recurrence from colorectal cancer.

Colosio A, Soyer P, Rousset P, Barbe C, Nguyen F, Bouché O, Hoeffel C.

J Magn Reson Imaging. 2014 Aug;40(2):306-13. doi: 10.1002/jmri.24366. Epub 2013 Oct 31.

PMID:
24311014
[PubMed - in process]
17.

Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis.

Paoletti X, Oba K, Bang YJ, Bleiberg H, Boku N, Bouché O, Catalano P, Fuse N, Michiels S, Moehler M, Morita S, Ohashi Y, Ohtsu A, Roth A, Rougier P, Sakamoto J, Sargent D, Sasako M, Shitara K, Thuss-Patience P, Van Cutsem E, Burzykowski T, Buyse M; GASTRIC group.

J Natl Cancer Inst. 2013 Nov 6;105(21):1667-70. doi: 10.1093/jnci/djt269. Epub 2013 Oct 9.

PMID:
24108811
[PubMed - indexed for MEDLINE]
18.

Laparoscopic thermal ablation of splenic metastases initial experience and present aspects.

Lardière-Deguelte S, de Mestier L, Amroun KL, Volet J, Cart P, Bouche O, Kianmanesh A.

J Visc Surg. 2013 Nov;150(5):355-8. doi: 10.1016/j.jviscsurg.2013.07.003. Epub 2013 Sep 4.

PMID:
24011663
[PubMed - indexed for MEDLINE]
19.

Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients.

Taly V, Pekin D, Benhaim L, Kotsopoulos SK, Le Corre D, Li X, Atochin I, Link DR, Griffiths AD, Pallier K, Blons H, Bouché O, Landi B, Hutchison JB, Laurent-Puig P.

Clin Chem. 2013 Dec;59(12):1722-31. doi: 10.1373/clinchem.2013.206359. Epub 2013 Aug 12.

PMID:
23938455
[PubMed - indexed for MEDLINE]
20.

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings.

Kubicka S, Greil R, André T, Bennouna J, Sastre J, Van Cutsem E, von Moos R, Osterlund P, Reyes-Rivera I, Müller T, Makrutzki M, Arnold D; ML18147 study investigators including AIO, GERCOR, FFCD, UNICANCER GI, TTD, BGDO, GEMCAD, and AGMT groups.

Ann Oncol. 2013 Sep;24(9):2342-9. doi: 10.1093/annonc/mdt231. Epub 2013 Jul 12.

PMID:
23852309
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk